TraceLink announces Russia compliance solution
Company helps customers navigate and company with "one of the most complicated track and trace regulations in the world".
TraceLink has announced its Russia compliance solution, providing companies with the ability to meet requirements for serialization, traceability, and compliance reporting in the Russian market, in advance of the country’s December 2019 enforcement deadline.
Under Russian Federal Law No. 425-FZ, medicines are required to be uniquely identified, or serialized, at multiple packaging levels including both aggregation and an expected application of cryptographic protections.
Companies across the supply chain, from manufacturer to pharmacy, are also required to track and capture a wide range of product movements and packaging changes for these medicines between transfers of custody, and report these events into the Russian central system — the Federal State Information System for Monitoring Drug Circulation (FSIS MDC) — via digitally-signed data exchange.
Manufacturers, including both those producing medicines outside of Russia as well as those with domestic production, will be responsible for up to 36 transactions, product events and notifications, including those affecting the product as it moves through internal distribution centers, customs, and third-party logistic providers serving the Russian market.
“Russia has one of the most complicated track and trace regulations in the world, requiring three times the amount of transactions than Europe. With proven experience developing compliance solutions for countries with similarly complex requirements, such as China, South Korea and Brazil, we already have customers that have invested in our Russia compliance solution, including the largest global pharmaceutical manufacturer that supplies to the Russian market,” said Shabbir Dahod, president, and CEO of TraceLink.
“Because the Russian authorities are still evolving the regulatory requirements and technical guidelines, TraceLink has, and will continue to invest heavily in dedicated resources to continuously monitor and interpret the regulations, which is critical in order to implement timely software updates and accommodate any regulatory changes.”
Built on TraceLink’s existing network tenant platform and instrumented with the core serialization, master data, integration, and compliance functionalities seen in all other TraceLink compliance solutions, the Russia solution gives customers a single destination to manage all of their global track and trace and serialization requirements.
Designed to meet the complex data choreography requirements for Russia compliance, TraceLink’s pre-configurable workflows and application logic enable companies to report on serialized events, and manage import, export, receipt, transfer, and shipment processes. The solution also securely and efficiently manages the complex reporting and notification capture process, supporting the complicated data schema and electronic signature process for Russia, employing a new level of technical sophistication not seen in other markets.
With TraceLink’s Russia solution, companies can leverage key components from TraceLink’s proven compliance platform, which are critical for a comprehensive system to comply with Russian requirements, including Serialization, Master Data, and Compliance Reporting.
Related News
-
News Patients vs Pharma – who will the Inflation Reduction Act affect the most?
The Inflation Reduction Act brought in by the Biden administration in 2022 aims to give better and more equitable access to healthcare in the USA. However, pharma companies are now concerned about the other potential costs of such legislation. -
News CPHI Podcast Series: What does the changing US Pharma market mean for industry and patients alike?
In this week's episode of the CPHI Podcast Series Lucy Chard, Digital Editor for CPHI Online is joined by James Manser to discuss the political and market changes in the US pharma field. -
News CPHI Barcelona Annual Report illuminates industry trends for 2024
The CPHI Annual Survey comes into it’s 7th year to report on the predicted trends for 2024. Over 250 pharma executives were asked 35 questions, with their answers informing the industry landscape for the next year, spanning all major pharma marke... -
News Which 10 drugs are open to price negotiation with Medicare in the USA?
The Centres for Medicare & Medicaid Services, under the Biden administration in the USA, has released a list of the 10 drugs that will be open to price negotiations as part of the new legislation under the Inflation Reduction Act (IRA). -
News EU Medical Devices Regulation causes unintended disappearances of medical devices for children, doctors state
Doctor groups and associations have appealed to the EU to correct the EU Medical Devices Regulation law that may cause unintended shortages of essential drug and medical devices for children and rare disease patients. -
News 10 Major Drug Approvals So Far in 2023
Last year, 37 novel drugs were approved by the FDA, this was a high number for such a category, and covered many fields including oncology, demonstrating how promising further research is, and how it is only continuing to build. To date, there are alre... -
News Detecting Alzheimer's disease with a simple lateral flow test
A novel rapid diagnostic test for early-stage Alzheimer's disease has been developed using a biomarker binder from Aptamer Group along with technology from Neuro-Bio, the neurodegenerative disease experts. -
News CPHI Podcast Series: outsourcing and manufacturing trends
Listen to the CPHI Podcast Series this June to hear Gil Roth of the PBOA speak with Digital Editor Lucy Chard about the biggest trends and topics to watch in pharma outsourcing and manufacturing at the minute.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance